Jane Street
DERM icon

Jane Street’s Journey Medical DERM Stock Holding History

Jane Street’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+28,400
New +$162K ﹤0.01% 10130

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street's DERM Position: Q2 2026 in Review

Jane Street opened a new position in Journey Medical (DERM) in Q2 2026: 320,021 shares worth $2.27M. The stake represents ﹤0.01% of the portfolio and ranks #4949 among its holdings. This is a return to the name: Jane Street previously reported a position in DERM as recently as Q4 2025.

Jane Street first reported a position in DERM in Q4 2023 and has held it in 4 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Jane Street held 320,021 shares of Journey Medical worth $2.27M as of Q2 2026.
  • Journey Medical was a new Jane Street position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4949 holding.
  • Jane Street first reported a position in Journey Medical in Q4 2023 and has held it in 4 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.